MTD Group Acquires Ypsomed's Pen Needles and Blood Glucose Monitoring Businesses

Tandem Diabetes Care Acquires Capillary Biomedical

July 21, 2022

Medical Devices

Tandem Diabetes Care, Inc. has acquired Capillary Biomedical, a developer of extended-wear insulin infusion set technology. The acquisition (terms not disclosed) brings Capillary's infusion-set R&D into Tandem's product portfolio to expand infusion set options and advance extended-wear solutions for insulin pump users.

Novaremed AG Acquires Metys Pharmaceuticals AG

September 7, 2021

Pharmaceuticals

Novaremed AG acquired Metys Pharmaceuticals AG in an all-share transaction, integrating Metys' clinical and preclinical non-opioid pain programs (including MP-101 and MP-103) into Novaremed's pipeline. The deal broadens Novaremed's focus from painful diabetic peripheral neuropathy (PDPN) to include chemotherapy-induced peripheral neuropathy (CIPN) and strengthens leadership with the election of Andrew J. Oakley to Novaremed's board.

Abbott Acquires Bigfoot Biomedical

September 5, 2023

Medical Devices

Abbott has entered a definitive agreement to acquire Bigfoot Biomedical, a developer of smart insulin management systems that integrate continuous glucose monitoring with connected insulin pen caps and a cloud-based provider portal. The acquisition will combine Abbott’s FreeStyle Libre CGM technology with Bigfoot’s dosing-capable pen cap platform to further develop personalized, connected diabetes care solutions; the deal is expected to close in Q3 2023 and financial terms were not disclosed.

Marketlab Acquires Assets of Medi‑Tech International Corporation

September 12, 2023

Medical Devices

Marketlab, a family-owned manufacturer of specialty healthcare products based in Caledonia, Michigan, has acquired the assets of Medi‑Tech International Corporation, a Brooklyn, New York‑based manufacturer of wound care, labor‑and‑delivery, and patient safety products. The acquisition expands Marketlab’s medical‑surgical and laboratory product portfolio and brings additional products, distribution partnerships, and GPO contracts into its offering to better serve IDNs and other healthcare customers.

Molded Devices (MDI) Acquires GlobalMed's Medical Tubing Operations from Schauenburg

November 9, 2022

Medical Devices

Molded Devices, Inc. (MDI), majority‑owned by TruArc Partners, acquired GlobalMed Inc. (Canada) and Schauenburg‑Truplast (China) from Schauenburg Hose Technology. The deal expands MDI’s extrusion and tubing capabilities for medical device OEMs, adding GlobalMed’s Canadian and Chinese production footprint and management team to MDI’s global manufacturing platform. Financial terms were not disclosed.

Myant Corp. Acquires mmHg Inc.

January 6, 2025

Healthcare Services

Myant Corp., a textile-computing and connected-health company based in Canada, has acquired mmHg Inc., a physician-led digital health firm specializing in remote blood pressure monitoring and cardiovascular risk management. The acquisition adds clinical-grade remote monitoring and cardiovascular analytics to Myant's offerings and expands Myant's market reach into the United States through mmHg's existing customer relationships and device partnerships.